Deutsche Bank Reiterates Hold Rating on National Health Investors, Inc. (NHI)

Market Context

National Health Investors, Inc. operates in the Real Estate sector. The stock currently trades at $76.42 with a market capitalization of $3.6B. The stock has gained 6.1% over the past 52 weeks.

Analyst coverage from Deutsche Bank provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for National Health Investors, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for National Health Investors, Inc.

Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jun 25, 2026	Deutsche Bank	Hold	N/A
Jun 15, 2026	BMO Capital	Outperform	N/A
Jun 12, 2026	Truist Securities	Buy	N/A
Jun 01, 2026	Wells Fargo	Equal-Weight	N/A
Apr 22, 2026	Wells Fargo	Equal-Weight	N/A

Related Tools: Analyst Ratings Dashboard | View NHI Stock Page